| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,157 | 2,966 | 3,512 | 3,496 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 4,157 | 2,966 | 3,512 | 3,496 | | | Operating Expenses | | Research Development | 6,967 | 7,844 | 7,586 | 7,858 | | Selling General and Administrative | 3,522 | 3,191 | 3,279 | 3,731 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,332) | (8,069) | (7,353) | (8,093) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 167 | 22 | 12 | 138 | | Earnings Before Interest And Taxes | (6,165) | (8,047) | (7,341) | (7,955) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (6,165) | (8,047) | (7,341) | (7,955) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,165) | (8,047) | (7,341) | (7,955) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,165) | (8,047) | (7,341) | (7,955) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,165) | ($8,047) | ($7,341) | ($7,955) |
|
0.83% Nasdaq 0.00%
Income Statement
